One major obstacle has been the variation in MRI data acquired across different sites, machines, and populations. This variability introduces measurement bias that obscures the subtle but crucial brain alterations in children with ADHD. Traditional harmonization efforts, such as ComBat, attempt to correct site and scanner differences statistically. While ComBat excels at neutralizing measurement bias, it tends to overcorrect by diminishing sampling bias—biological variability inherent to the study population. This overcorrection risks masking meaningful biological features, leading to ambiguous or conflicting conclusions about brain volume differences in ADHD.

In a groundbreaking new study, researchers from Japan introduce the traveling-subject (TS) harmonization method—a novel approach designed to disentangle measurement bias from sampling bias more effectively. The TS method leverages multiple MRI scans of the same individual obtained from different scanners to precisely quantify and correct scanner-specific measurement variations. By applying this method, the researchers achieved more accurate, harmonized brain imaging data across sites, preserving essential biological variance that traditional techniques overlook.

The study was a collaborative effort encompassing experts from the University of Fukui, Chiba University, and The University of Osaka. Assistant Professor Qiulu Shou and Associate Professor Yoshifumi Mizuno spearheaded the initiative, validating the TS method on an independent large-scale dataset. This dataset involved 14 traveling subjects who underwent scans on four distinct MRI machines from multiple institutions over several months. These reference scans enabled the researchers to isolate measurement discrepancies unique to each MRI scanner with unparalleled precision.

Following scanner bias calibration, the team applied the corrections to data from over 290 children enrolled in the Child Developmental MRI (CDM) database. The CDM database, an ambitious joint venture by the collaborating universities, aims to collect neuroimaging data on more than 1,000 children to enhance our understanding of brain development and neurodevelopmental disorders. Subjects consisted of typically developing children as well as children diagnosed with ADHD, allowing rigorous comparison of gray matter volume (GMV) across groups while accounting for site variations.

Crucially, the TS harmonization method not only reduced measurement biases significantly compared to raw data but also maintained sampling bias—preserving biological differences between individuals. This contrasts with ComBat, which although effective at measurement bias reduction, substantially reduced sampling bias and potentially diluted neurobiological signals. Such preservation of biological variance is essential for identifying genuine disease-related brain structure changes, with far-reaching implications for diagnostic imaging research.

Applying TS correction, the researchers observed robust regional gray matter reductions in the frontotemporal lobes of children with ADHD compared to typically developing peers. These brain regions are intimately involved in cognitive processes frequently impaired in ADHD, including attentional control, executive functioning, and emotional regulation. The detected volumetric decreases provide compelling evidence for structural abnormalities localized to networks underpinning core ADHD symptomatology.

The implications of these findings extend beyond academic interest. Harmonized brain imaging datasets that accurately reflect both measurement consistency and biological variability empower scientists and clinicians to identify reliable neuroimaging biomarkers. Such biomarkers could revolutionize ADHD diagnostics by enabling early and objective identification of affected children, paving the way for targeted interventions tailored to individual neural profiles. Moreover, longitudinal monitoring of these markers might gauge treatment efficacy and neurological development trajectories over time.

This study exemplifies the critical importance of addressing measurement bias in multi-site neuroimaging research. As collaborative studies expand globally, harmonization methods like TS will be indispensable for integrating data across institutions and scanner types without compromising biological insights. The synergy between methodological rigor and clinical relevance embodied in this work sets a new standard for ADHD neuroimaging and offers hope for breakthroughs in understanding and treating this prevalent disorder.

Dr. Shou emphasized, “The TS harmonization framework enables us to disentangle technical artifacts from true neurobiological signals in multi-site data, facilitating more accurate detection of brain structural abnormalities in ADHD.” Associate Professor Mizuno added, “Our results underscore the presence of distinct brain morphology alterations in key cognitive regions, reinforcing the biological basis of ADHD and guiding future personalized therapeutic strategies.”

Looking forward, the researchers advocate for wider adoption of the TS harmonization approach across neurodevelopmental disorder research. By combining robust data correction with large-scale data aggregation, the field can generate reproducible and clinically actionable findings. Ultimately, this convergence of advanced imaging methodology and neuropsychiatric inquiry holds the promise of transforming strategies for diagnosing, treating, and understanding ADHD, thereby improving outcomes for millions of affected children worldwide.

Subject of Research: People

Article Title: Brain structure characteristics in children with attention deficit/hyperactivity disorder elucidated using traveling-subject harmonization

News Publication Date: 8-Aug-2025

References:
DOI: 10.1038/s41380-025-03142-6

Image Credits: Associate Professor Yoshifumi Mizuno from the University of Fukui, Japan

Keywords: Neuroimaging, Neuroscience, Imaging, Cognitive neuroscience, Human brain, Medical imaging, Functional neuroimaging, Connectomics, Tomography, Functional magnetic resonance imaging, Nuclear magnetic resonance, Magnetic resonance imaging, Research methods, Psychological science, Cognitive psychology, Cognitive development, Learning disabilities, Brain activity maps, Attention deficit hyperactivity disorder

Traditionally, ADHD has been frequently examined through the lens of behavioral symptoms and its frequent co-occurrence with mood and disruptive behavior disorders, often leading to conflated diagnostic and therapeutic strategies. However, this new research emphasizes the distinct polygenic influences that target neural circuits responsible for emotional and motivational processing, thereby refuting the notion that ADHD-related neurophysiological traits are merely extensions of anxiety, depression, or ODD symptomatology. This is a crucial distinction, as it suggests that ADHD’s genetic risk contributes specifically to neural pathways governing affective and motivational states.

The authors utilized a comprehensive polygenic risk scoring methodology amalgamating genome-wide association study (GWAS) data with electrophysiological recordings of event-related potentials (ERPs) obtained from a large, well-characterized cohort. Such an integrative approach allowed the dissociation of ADHD-linked genetic variants’ effects from those associated with anxiety and mood disorders. Notably, the electrophysiological markers that correlated with polygenic ADHD liability were primarily related to components implicated in affective salience and motivational drive, emphasizing the neurofunctional specificity of these findings.

ADHD’s heterogeneity has long posed challenges for researchers and clinicians alike, impeding the development of precision diagnostics and targeted interventions. By elucidating how polygenic burden for ADHD uniquely influences brain electrophysiology beyond overlapping psychiatric domains, this study paves the way for more nuanced biomarker identification. Electrophysiological indices, such as certain ERP components related to affective response processing, may thus serve as objective biological signatures to augment clinical assessment and intervention strategies.

One particularly compelling dimension of the research is its exploration of affective-motivational neural circuits, a domain often overshadowed by the predominant focus on executive dysfunction and attentional control in ADHD research. The findings highlight that the genetic liability to ADHD also manifests through modulation of brain areas integral to the processing of emotional value and reward-related cues. This neurofunctional insight aligns with emerging theories positing that motivational impairments contribute substantively to ADHD symptomatology, broadening the conceptual framework beyond purely cognitive deficits.

The study’s multidisciplinary methodology underscores the importance of integrating genetic epidemiology with neurophysiological data to decode psychiatric disorders’ complexity. By leveraging high-resolution electrophysiological techniques, such as ERP analysis, alongside polygenic risk assessments, the authors effectively decode the subtle but meaningful ways in which genetic predispositions shape neural dynamics. This fusion of methodologies represents a significant advancement over traditional single-modality studies that often fail to capture the multidimensional nature of psychiatric conditions.

Moreover, the research meticulously controls for confounding comorbidities, ensuring that the observed electrophysiological signatures are not artifacts of overlapping anxiety, depressive, or oppositional symptoms. This methodological rigor strengthens the argument for ADHD’s unique affective-motivational neurogenetic profile and challenges clinicians to reconsider differential diagnoses where symptom overlap may obscure underlying etiologies.

Importantly, the implications of these findings extend beyond academic insights to practical applications in personalized medicine. Understanding the specific neural and genetic pathways implicated in ADHD can catalyze the development of targeted neuromodulatory therapies and pharmacological interventions tailored to affective-motivational deficits. Such bespoke treatment avenues hold promise for improving outcomes and quality of life in individuals with ADHD, especially those who do not respond optimally to conventional stimulant-based therapies.

Furthermore, this study contributes to the growing body of literature emphasizing the dimensional nature of psychiatric disorders. By unraveling the polygenic and electrophysiological fabric of ADHD independently from related disorders, the authors advocate for refined diagnostic frameworks that acknowledge both shared and distinct biological mechanisms across psychiatric spectra. This shift towards neurobiologically informed classification aligns with initiatives such as the Research Domain Criteria (RDoC) project, which seeks to transcend traditional categorical nosologies.

The discovery also raises intriguing questions about the developmental trajectory of affective-motivational processing in individuals with high polygenic risk for ADHD. Longitudinal studies motivated by these findings could elucidate how genetic predispositions interact with environmental factors to shape neurodevelopmental outcomes across the lifespan. Such research avenues promise to shed light on critical windows for intervention and prevention strategies tailored to genetic and neurofunctional profiles.

Crucially, the electrophysiological affective-motivational markers identified may serve as predictive tools for disease course and treatment responsiveness. If validated in clinical settings, these biomarkers could revolutionize early identification efforts and inform more effective allocation of therapeutic resources. This is particularly relevant in pediatric populations, where timely diagnosis and intervention can significantly alter developmental trajectories.

The research team also contemplates the translational potential of these findings in enhancing neurofeedback and cognitive-behavioral therapy protocols. By targeting the affective-motivational neural networks influenced by polygenic ADHD liability, novel behavioral interventions may be devised to strengthen deficient neural processing patterns, thereby mitigating core symptoms and associated functional impairments.

In sum, the study by Ágrez and colleagues represents a seminal contribution to psychiatric neuroscience, untangling the polygenic influences on affective and motivational processing that lie at the heart of ADHD. It challenges conventional paradigms by delineating electrophysiological signatures unique to ADHD’s genetic architecture, independent of commonly comorbid psychiatric disorders. These insights not only deepen our understanding of ADHD’s neurobiology but also chart promising directions for clinical innovation and personalized mental health care.

As the scientific community continues to grapple with the complexity of psychiatric genetics and brain function, this research exemplifies an integrative and precise approach necessary to unravel multifaceted disorders such as ADHD. The synergy between polygenic risk modeling and electrophysiological investigation heralds a new era of psychiatry where genetic predispositions can be mapped onto specific neural circuits with unprecedented clarity, ultimately guiding more effective diagnosis, prognosis, and treatment strategies.

Looking forward, the integration of this neurogenetic framework with emerging artificial intelligence and machine learning approaches may further enhance predictive modeling and individualized intervention planning. Harnessing multidimensional data streams—genetic, electrophysiological, behavioral—will be paramount to realizing the full clinical potential of these groundbreaking findings.

Subject of Research:

Polygenic liability for ADHD and its association with electrophysiological affective-motivational processing beyond comorbid anxiety, depression, and ODD.

Article Title:

Not just old wine in new bottles: Polygenic liability for ADHD is associated with electrophysiological affective-motivational processing beyond anxiety, depression, and ODD.

Article References:

Ágrez, K., Visky, Z., Hámori, G. et al. Not just old wine in new bottles: Polygenic liability for ADHD is associated with electrophysiological affective-motivational processing beyond anxiety, depression, and ODD. Transl Psychiatry 15, 213 (2025). https://doi.org/10.1038/s41398-025-03434-z

Image Credits: AI Generated

DOI: https://doi.org/10.1038/s41398-025-03434-z